Check out the latest features and columns!

Pharmaceutical Executive January 2023

January's Executive Profile features Natalie Bickford, chief people officer at Sanofi

Enabling Authenticity

Pharm Exec's 18th Annual Pipeline Report focuses on spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics

Testing the Limits

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences stakeholders

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Click for more information and to submit a nomination

Pharmaceutical Executive 2023 Emerging Pharma Leaders Awards

Carolina Ahrendt is an associate principal consultant, program leader, for Halloran Consulting Group.

Pam Wilson is a lead consultant, program manager, for Halloran Consulting Group.

Julia Libunao is a lead consultant, strategy and program leadership, for Halloran Consulting Group.

Articles

Delivering value with enterprise program management.

Why Program Management is the Key to Success for Life Science Companies 

BMS launched a new direct-to-consumer (DTC) campaign for SOTYKTU™ (deucravacitinib) for the plaque psoriasis community.

Bristol Myers Squibb Launch New DTC Campaign in Plaque Psoriasis

U.S. Food and Drug Administration has greenlighted the use of Trodelvy for a third indication.

Gilead's Breast Cancer Drug Gets U.S. FDA Approval for Third Indication

The Ad Club is leveraging AnyClip's AI-powered genius+ platform
to drive discoverability, in-video search and interactivity to deliver
their robust library of club programming to its members.

Advertising Club of New York Launches Searchable, Interactive Digital Video Portal

Bruce Liu is a partner at Simon-Kucher & Partners, leading its life sciences division in greater China.

Justinian Liu is a senior consultant for Simon-Kucher.

Duo Xu is a senior consultant for Simon-Kucher.

Shiying He is a senior consultant for Simon-Kucher.

Selene Peng is a senior consultant for Simon-Kucher.

Despite the twists and turns, 2022 turned out to be a banner year for National Reimbursement Drug List’s new inclusions—and with welcomed upgrades to bidding and renewal rules.    

China’s 2022 NRDL Readout

Dr. Arturo Loaiza-Bonilla, MD, is the co-founder and chief medical officer of Massive Bio.

Overcoming persistent barriers to health equity in oncology trials will require innovation and cooperation.

Health Equity Barriers in Oncology Trials

The platform is designed to reduce barriers to care for patients with COVID-19.

Pfizer and Ada Health Inc. To Launch Nationwide Online COVID-19 Care Journey

Jill Wechsler is Pharm Exec's Washington Corespondent

Proposed realignment of the Office of Regulatory Affairs would impact oversight of drugs and medical devices as well.

FDA Food Center Reorganization Puts Field Inspections in Limbo

 and can be reached at mrivers@mjhlifesciences.com.

Podcasts

Piper Trelstad, PhD, head of CMC, Bill & Melinda Gates Medical Research Institute, shares her experience being a woman in pharma, particularly at the C-suite level, as well as how to have more diversity in the industry.

Working in a Male-Dominated Field

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Pharm Exec details the career of Rajesh K. Rajpal, MD, the chief medical officer and global head of clinical and medical affairs at J&J Vision.

Featured Content

Pharmaceutical Executive January 2023

Enabling Authenticity

Testing the Limits

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharmaceutical Executive 2023 Emerging Pharma Leaders Awards